OBJECTIVES:
To evaluate factors predictive of post-discharge opioid prescription refills after female pelvic reconstructive surgery. MATERIALS AND METHODS: After IRB approval, a retrospective chart review using electronic medical records was performed on patients who underwent surgery within the academic urogynecology practice from January 1, 2018, to June 30, 2018, inclusive. The number of patients who needed a narcotic refill in the postoperative period (within eight weeks of surgery) was determined. Demographic information, patient and surgical factors, including information on narcotic use during the hospital stay were compared between patients who received refills vs. patient who did not. Calls during the postoperative period were tabulated. All narcotic information was converted to mg equivalent oral morphine (MME). Continuous data were evaluated with a Student's t-test or ANOVA; categorical data were evaluated with a chi square test. Results yielding p<0.05 were deemed statistically significant. RESULTS: Two hundred sixty-five patients underwent pelvic reconstructive surgery in the designated period, of which 262 records were included in this study. Seventeen (6.5%) patients received a narcotic prescription refill. Refill recipients received more intravenous (IV) (p¼0.001) and oral (PO) (p¼0.007) in-hospital narcotics compared to those who did not. Patients who were narcotic non-users in the hospital were less likely to require a refill post-discharge (p¼0.016). There was no statistical difference in any other demographic, clinical or surgical factors between patients who received refills vs. patients who did not. CONCLUSION: The demand for opioid prescriptions refills after pelvic reconstructive surgery is low. Amount of in-hospital postoperative narcotic use can be a valuable predictor of patients needing additional opioid prescriptions post-discharge. Prospective studies are warranted to evaluate definitive factors that predict patients requiring opioid prescription refills post-discharge. 
DISCLOSURE OF RELEVANT

OBJECTIVES:
To compare laparoscopic and vaginal approaches of Uterosacral Ligament Vault Suspension (USLS) by perioperative data, short-term complications, rates of successful concomitant adnexal surgery and procedural efficacy. MATERIALS AND METHODS: Retrospective cohort of USLS procedures performed at the time of hysterectomy at a tertiary care center over a three-year period. Patient demographics, surgical data, concomitant adnexal procedures, and complications were abstracted from a surgical database and compared using parametric or non-parametric tests as appropriate. Validated questionnaires (POPDI-6, UDI-6, PROMIS) were used to collect information on recurrence and longterm complications. Patients were analyzed both according to attention to treat analysis based on intended approach and by completed route of surgery to deal with intra-operative conversions. RESULTS: Two hundred six patients met criteria for inclusion, 152 underwent vaginal USLS (V-USLS) and 54 laparoscopic USLS (L-USLS). No statistically significant differences in mean case time, post-operative length of stay or peri-op infection was found. While no ureteric obstructions occurred in the L-USLS group, in the V-USLS 14 (9%) obstructions occurred (p¼0.023). Post-operative urinary retention was higher with V-USLS (31% vs 15%, p¼0.024). Rates of successfully completed adnexal surgery differed (56% vs 98%, p<0.001) in favor of L-USLS. Patient reported symptomatic recurrence of prolapse was higher in the V-USLS group (41% vs. 24%, p¼0.046); despite this re-treatment did not differ between the groups (0% vs. 7%, p¼0.113). CONCLUSION: Laparoscopic uterosacral vault suspension offered higher rates of patient reported cure, lower rates of intra-operative ureteric kinking, lower rates of failing institutional post-op bladder protocol, and higher rates of successful concomitant adnexal surgery without incurring longer total operative case times or higher rates of vascular or visceral injury. These differences may influence surgical decision making in terms of which approach to choose when performing uterosacral vault suspension at the time of hysterectomy. OBJECTIVES: There is limited data to inform physicians' counseling regarding mode of delivery for pregnancies after surgery for pelvic organ prolapse (POP). The aim of this study was to review the medical decision making and clinical outcomes of patients delivering after prolapse surgery within a large healthcare organization.
MATERIALS AND METHODS:
We performed a retrospective case series of patients who were identified by Current Procedural Terminology (CPT) coding for POP surgery between 2007 and 2017. Identified electronic medical records were referenced against a live birth registry within the healthcare system. Demographic and clinical data were abstracted through extensive, standardized physician review of the identified electronic medical records. RESULTS: Twenty patients were included in the analysis. The distribution of surgeries was as follows: 17 patients had a posterior colporrhaphy, 10 patients had an anterior colporrhaphy, and 5 patients had an apical suspension. Seven patients (35%) had a concomitant midurethral sling. The mean interval between surgery and first delivery was 28.6 months (range 8.1 -93.5). One patient (5%) endorsed recurrent prolapse symptoms between the POP surgery and pregnancy, and none of the remaining 19 patients reported recurrent prolapse symptoms before or during the pregnancy. There were no pregnancy complications related to the prior POP surgery. Nine of the patients (45%) were delivered by Cesarean section (CS). Four patients were counseled to have a CS due to the prior POP surgery, 3 patients electively chose to have a primary CS due to the POP surgery regardless of physician counseling, 1 patient chose to have an elective repeat CS, and 1 patient had a CS due to obstructed labor. A FPMRS provider was specifically consulted for delivery recommendations for 6 patients (30%), and recommended a CS for 3 of the 6 patients (50%). Eleven patients had spontaneous vaginal delivery and none of them sustained greater than a second degree perineal laceration. The mean interval follow-up after delivery was 42.1 months (range 1.9 -86.7). Three patients (15%) reported subjective recurrent prolapse symptoms after delivery, and 2 of these patients were planning to proceed with surgery at time of this analysis. CONCLUSION: This case series corroborates previous series demonstrating the safety and durability of POP surgery during subsequent pregnancy. In this series, >75% of the patients who were delivered by CS were due to the physician's or patient's concerns regarding the prior prolapse surgery. Obstetrical physicians sought out the opinion of a FPMRS provider for delivery recommendations in only 30% of patients, and the recommendation varied by provider. Further research evaluating the durability of various reconstructive surgeries in subsequent pregnancies is needed to help guide FPMRS physicians' recommendations.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS:
Kristen Buono: Nothing to disclose; Atieh Novin: Nothing to disclose; Emily Whitcomb: Nothing to disclose. 
OBJECTIVES:
The bladder supports a dynamic microbiome which can be used to predict lower urinary tract dysfunction and response to treatment. However, there is insufficient data to determine whether voided urine samples provide equivalent accuracy to catheterized samples. We hypothesize that the true urinary bladder microbiome can be determined by the subtraction of the vulvovaginal microbiome from the voided urine microbiome. We therefore aimed to develop a taxonomical comparison between voided and catheterized urine samples and to create a vulvovaginal contamination prediction model.
MATERIALS AND METHODS:
Women presenting for clinical care to a urogynecologist with no clinical evidence of urinary tract infection were approached for study participation. Voided urine samples followed by catheterized urine samples and vaginal swabs were obtained from 23 women. A comparison cohort of 23 women provided only voided and catheterized urine samples. Bacterial DNA was isolated from the urine and vaginal swabs and 16S rRNA amplicon sequencing was used to characterize the microbiota. Samples were processed using the QIIME pipeline, using DeBlur to characterize sequences to the sub-species level, and sequences were annotated to known taxa using GreenGenes. Non-parametric statistical approaches were used to interpret these data. RESULTS: Forty-four voided urine samples, 40 cathed urine samples and 22 vaginal swabs were sequence positive. Voided samples were dominated by taxa associated with Lactobacillus and Clostridiales. Catheterized samples were dominated by Actinobacter, Escherichia coli and Enterobacter species. Vaginal swab samples were either dominated by Lactobacillus species or composed of a polymicrobial community with no dominant species. There was significant overlap between vaginal and voided urinary taxa on the Principal Coordinates Analysis (PCoA) plots demonstrating that vaginal operational taxonomic units (OTUs) represented most of the urinary sequence data and the remaining non-vaginal taxa were low-abundance OTUs such as Finegoldia and Peptoniphilus. These species are opportunistic skin pathogens and likely represent further contamination of the voided specimens. To determine whether the vaginal taxa could be filtered out from the voided specimens to predict the catheterized taxa, multiple models of "true vaginal taxa" were created by setting a variable threshold number of swab samples an OTU had to present in to be considered a "true vaginal taxon." PCoA plots were then created for the variable filtered voided samples and compared to the catheter samples. There was no threshold level of vaginal taxa that could be filtered out that would demonstrate that the voided microbiome was equivalent to the catheterized microbiome. CONCLUSION: Catheterized and voided urine microbiomes are not interchangeable, but the differences cannot be accounted for simply from vulvovaginal contamination.
